Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risks and benefits of sharing patient information on social media: a digital dilemma.
van der Boon RMA, Camm AJ, Aguiar C, Biasin E, Breithardt G, Bueno H, Drossart I, Hoppe N, Kamenjasevic E, Ladeiras-Lopes R, McGreavy P, Lanzer P, Vidal-Perez R, Bruining N. van der Boon RMA, et al. Among authors: lanzer p. Eur Heart J Digit Health. 2024 Feb 12;5(3):199-207. doi: 10.1093/ehjdh/ztae009. eCollection 2024 May. Eur Heart J Digit Health. 2024. PMID: 38774369 Free PMC article. Review.
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial.
Borlich M, Zeymer U, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R, Iden L, Richardt G, Toelg R. Borlich M, et al. Among authors: lanzer p. Cardiol Ther. 2024 Mar;13(1):89-101. doi: 10.1007/s40119-023-00343-4. Epub 2023 Dec 6. Cardiol Ther. 2024. PMID: 38055177 Free PMC article.
Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice.
Zeymer U, Toelg R, Wienbergen H, Hobbach HP, Cuneo A, Bekeredjian R, Ritter O, Hailer B, Hertting K, Hennersdorf M, Scholtz W, Lanzer P, Mudra H, Schwefer M, Schwimmbeck PL, Liebetrau C, Thiele H, Claas C, Riemer T, Zahn R. Zeymer U, et al. Among authors: lanzer p. Am J Cardiol. 2023 Feb 15;189:31-37. doi: 10.1016/j.amjcard.2022.11.009. Epub 2022 Dec 6. Am J Cardiol. 2023. PMID: 36493580
Exploring disease which does not exist.
Lanzer P. Lanzer P. Eur Heart J. 2023 Apr 1;44(13):1103-1104. doi: 10.1093/eurheartj/ehac622. Eur Heart J. 2023. PMID: 36380353 No abstract available.
Polypill Strategy in Secondary Cardiovascular Prevention.
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuño F, Vazquez Rodriguez JM, Domingo-Fernández A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibañez B, Fuster V; SECURE Investigators. Castellano JM, et al. N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26. N Engl J Med. 2022. PMID: 36018037 Clinical Trial.
86 results